Stock listing
NASDAQ:ADMS Adamas Pharmaceuticals Inc Stock
Follow Adamas Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ADMS
$8.22 USD
Close on Nov 24, 2021 · No longer trades
- Lowest – highest close
- $1.99 – $42.65 USDSince Apr 10, 2014 · lowest Mar 18, 2020 · highest Jan 23, 2018
Delisted NASDAQ:ADMS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ADMS
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Rajiv Patni Other companies: Septerna, Inc. (Chief Medical Officer · Since at least Aug 24, 2026); BioXcel Therapeutics, Inc. (Director · Since at least Jan 15, 2025); Quince Therapeutics, Inc. (Director · Since at least Feb 15, 2024); Reata Pharmaceuticals Inc (EVP, Chief R&D Officer · Jun 12, 2023 – Sep 26, 2023 · Past); Portola Pharmaceuticals Inc (EVP, CMO · Feb 3, 2020 – Jul 2, 2020 · Past); Ocera Therapeutics Inc (Chief Development Officer · Sep 2, 2014 – May 7, 2015 · Past) | Chief Medical Officer · Jun 8, 2015 – Apr 8, 2019 · Past |
| Sara Grootwassink Lewis Other companies: Freeport-McMoRan, Inc. (Director · Since at least Aug 2, 2021); Healthpeak Properties, Inc. (Director · Since at least Nov 5, 2019); Weyerhaeuser Company (Director · Since at least Feb 19, 2016); Plum Creek Timber Company. Inc (Director · Nov 5, 2013 – Feb 19, 2016 · Past); CapitalSource Inc (Director · Apr 26, 2012 – Apr 7, 2014 · Past) | Director · Apr 9, 2014 – May 14, 2015 · Past |
| Jennifer J. Rhodes Other companies: ACADIA Pharmaceuticals Inc. (Chief Legal Officer and Secretary · Since at least Feb 6, 2024); Elicio Therapeutics, Inc. (See Remarks · Feb 4, 2021 – Mar 2, 2022 · Past); Medivation Inc (GC & Corporate Secretary · Mar 26, 2013 – Mar 16, 2015 · Past) | CBO, GC & Compliance Officer · Apr 11, 2016 – Jun 20, 2019 · Past |
| Spyros Papapetropoulos Other companies: Neuphoria Therapeutics Inc. (President and CEO, Director · Since at least Jul 1, 2024); Lipocine Inc. (Director · Since at least Apr 11, 2022); Vigil Neuroscience Inc (Chief Medical Officer · Jan 6, 2022 – Nov 18, 2022 · Past) | Director · Nov 22, 2020 – Nov 24, 2021 · Past |
| Anna Richo Other companies: Illumina, Inc. (Director · Since at least May 16, 2024); Exelon Corporation (Independent Director since 2023 · Since at least Aug 1, 2023) | Director · Aug 29, 2020 – Nov 24, 2021 · Past |
| David L. Mahoney Other companies: Corcept Therapeutics Incorporated (Director · Since at least Nov 16, 2017); Gen Digital Inc. (Director · May 17, 2018 – May 14, 2019 · Past) | Director · Nov 29, 2017 – Nov 24, 2021 · Past |
| Grace Shin | General Counsel · Dec 1, 2014 – Dec 1, 2014 · Past |
| Gregory T Went | Chief Executive Officer, Director · Jun 15, 2016 – Apr 8, 2019 · Past |
| Ivan M Lieberburg | Director · Apr 9, 2014 – Jun 3, 2020 · Past |
| Natalie McClure | SVP, Product Development · Apr 18, 2016 – Apr 18, 2016 · Past |
Log in to ask 6ix AI your own questions about Adamas Pharmaceuticals Inc.